Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer

ClinicalTrials.gov ID: NCT00343460

Public ClinicalTrials.gov record NCT00343460. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 9:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Pivotal Phase 3 Observer-Blind, Randomized Clinical Trial of the Efficacy and Safety of APF530 Compared to Aloxi For The Prevention of Acute-Onset and Delayed-Onset Chemotherapy-Induced Nausea and Vomiting Following The Administration of Either Moderately or Highly Emetogenic Chemotherapy Regimens

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This randomized phase III trial is studying APF530 and dexamethasone to see how well they work compared with palonosetron and dexamethasone in preventing nausea and vomiting in patients receiving chemotherapy for cancer.

Study identification

NCT ID
NCT00343460
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Heron Therapeutics
Industry
Enrollment
1,428 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2006 (Type not available)
Primary completion
Sep 2008 (Actual)
Completion
Feb 2009 (Actual)
Last update posted
Mar 2, 2026

2006 – 2009

United States locations

U.S. sites
52
U.S. states
27
U.S. cities
49
Facility City State ZIP Site status
Anniston Oncology, PC Anniston Alabama 36207 —
Palo Verde Hematology Oncology - Glendale Glendale Arizona 85304 —
Arizona Clinical Research Center, Incorporated Tucson Arizona 85715 —
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
Pacific Cancer Medical Center, Incorporated Anaheim California 92801 —
Southbay Oncology / Hematology Medical Group Campbell California 95008 —
Compassionate Cancer Care Medical Group Incorporated - Corona Corona California 92882 —
Compassionate Cancer Care Medical Group Incorporated - Fountain Valley Fountain Valley California 92708 —
Advanced Research Management Services, Incorporated Los Angeles California 90057 —
Kenmar Research Institute Los Angeles California 90057 —
Medical Oncology Care Associates - Orange Orange California 92868 —
Eastern Connecticut Hematology and Oncology Associates Norwich Connecticut 06360 —
Providence Hospital Washington D.C. District of Columbia 20017 —
Pasco Pinellas Cancer Center - New Port Richey New Port Richey Florida 34689 —
Innovative Medical Research of South Florida, Incorporated North Miami Beach Florida 33179-4709 —
Columbus Clinic, PC Columbus Georgia 31901 —
Clintell, Incorporated Skokie Illinois 60077 —
Investigative Clinical Research, LLC Indianapolis Indiana 46254 —
Cancer Center of Indiana New Albany Indiana 47150 —
Family Medicine of Vincennes Clinical Trial Center Vincennes Indiana 47591 —
Medical Center Vincennes Vincennes Indiana 47591 —
Kentucky Cancer Clinic - Hazard Hazard Kentucky 41701 —
Kentuckiana Cancer Institute, PLLC Louisville Kentucky 40202 —
Hematology-Medical Oncology Associates at Central Maine Comprehensive Cancer Center Lewiston Maine 04240 —
Mercy Medical Center Baltimore Maryland 21202-2165 —
Center for Cancer and Blood Disorders at Suburban Hospital Bethesda Maryland 20817 —
Center for Clinical Research at Washington County Hospital Hagerstown Maryland 21740 —
Northern Michigan Hospital Petoskey Michigan 49770 —
Regional Cancer Center at Singing River Hospital Pascagoula Mississippi 39581 —
Kansas City Cancer Centers - South Kansas City Missouri 64131 —
Star Hematology & Oncology Phillipsburg New Jersey 08865 —
Veterans Affairs Medical Center - Buffalo Buffalo New York 14215 —
Falck Cancer Center at Arnot Ogden Medical Center Elmira New York 14905 —
Hudson Valley Hematology-Oncology Associates - Poughkeepsie Poughkeepsie New York 12601 —
Comprehensive Cancer Center at Pardee Hospital Hendersonville North Carolina 28791 —
Boice Willis Clinic, PA Rocky Mount North Carolina 27804 —
Eastern North Carolina Medical Group, PLLC Rocky Mount North Carolina 27804 —
McDowell Cancer Center at Akron General Medical Center Akron Ohio 44302 —
Gabrail Cancer Center - Canton Office Canton Ohio 44718 —
Gabrail Cancer Center - Dover Office Dover Ohio 44622 —
MedCentral - Mansfield Hospital Mansfield Ohio 44903 —
Signal Point Hematology Oncology Incorporated Middletown Ohio 45042 —
Cancer Treatment Centers of America at Southwestern Regional Medical Center Tulsa Oklahoma 74133-4564 —
Pottsville Cancer Clinic Pottsville Pennsylvania 17901 —
Charleston Hematology Oncology Associates, PA Charleston South Carolina 29403 —
Julie and Ben Rogers Cancer Institute at Memorial Hermann Baptist Beaumont Hospital Beaumont Texas 77701 —
Texas Cancer Clinic San Antonio Texas 78240 —
Cancer Outreach Associates - Abingdon Abingdon Virginia 24211 —
Virginia Oncology Care, PC Richlands Virginia 24641 —
Western Washington Oncology, Incorporated, PS at Western Washington Cancer Center Lacey Washington 98503 —
MultiCare Regional Cancer Center at Tacoma General Hospital Tacoma Washington 98405 —
Mary Babb Randolph Cancer Center at West Virginia University Hospitals Morgantown West Virginia 26506-9300 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00343460, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2026 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00343460 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →